Growth Metrics

Bio-Rad Laboratories (BIO-B) Cash from Operations Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Bio-Rad Laboratories - - 309.40 Mn 3.28%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.28%
Dec 31, 2025 27.47%
Sep 30, 2025 122.40%
Jun 30, 2025 29.78%
Mar 31, 2025 37.02%
Dec 31, 2024 -10.09%
Sep 30, 2024 -10.79%
Jun 30, 2024 -14.21%
Mar 31, 2024 -14.99%
Dec 31, 2023 -34.96%
Sep 30, 2023 -10.36%
Jun 30, 2023 2.11%
Mar 31, 2023 16.03%
Dec 31, 2022 -20.73%
Sep 30, 2022 -52.07%
Jun 30, 2022 -30.00%
Mar 31, 2022 5.59%
Dec 31, 2021 17.63%
Sep 30, 2021 54.66%
Jun 30, 2021 25.69%
Mar 31, 2021 41.21%
Dec 31, 2020 61.93%
Sep 30, 2020 68.27%
Jun 30, 2020 13.81%
Mar 31, 2020 46.09%
Dec 31, 2019 19.02%
Sep 30, 2019 24.59%
Jun 30, 2019 26.29%
Mar 31, 2019 97.98%
Dec 31, 2018 42.96%
Sep 30, 2018 -8.87%
Jun 30, 2018 26.42%
Mar 31, 2018 11.07%
Dec 31, 2017 19.92%
Sep 30, 2017 -32.02%
Jun 30, 2017 -6.67%
Mar 31, 2017 -41.90%
Dec 31, 2016 10.36%
Sep 30, 2016 -2.00%
Jun 30, 2016 57.53%
Mar 31, 2016 -32.19%
Dec 31, 2015 -25.30%
Sep 30, 2015 4.87%
Jun 30, 2015 -19.42%
Mar 31, 2015 -5.83%
Dec 31, 2014 -20.98%
Sep 30, 2014 21.01%
Jun 30, 2014 -11.34%
Mar 31, 2014 49.10%
Dec 31, 2013 -11.11%
Sep 30, 2013 -6.40%
Jun 30, 2013 -18.45%
Mar 31, 2013 2.55%
Dec 31, 2012 -9.34%
Sep 30, 2012 -9.89%